申请人:Karstens Willem Frederik Johan
公开号:US20140038942A1
公开(公告)日:2014-02-06
The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.
本发明涉及公式(I)或其药学上可接受的盐或溶剂的化合物。这样的化合物可用于治疗RORgammaT介导的疾病或病况。